Fact CheckerSign in

NCT00165425Active, not recruiting

Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation

Source: ClinicalTrials.gov · Last updated 10 Sept 2025

Brief summary (registry, in English)

The main purpose of this study is to determine if it is possible to put into practice a cardiac screening program for survivors of Hodgkin's disease. In this study, we would also like to screen for cardiac risk factors that can be modified either through life-style changes or medications, to uncover significant abnormal heart findings in which treatments may be needed, and to see if there is a link between cardiac health and quality of life.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
210 (actual)
First submitted
9 Sept 2005
Start date
Feb 2004
Primary completion date
Oct 2007
Lead sponsor
Dana-Farber Cancer Institute
NCT number
NCT00165425

What you commit to

  • Study type: Interventional
  • Participants enrolled: 210
  • From Feb 2004 to the primary completion date, Oct 2007
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients treated for Hodgkin's disease outside of Brigham and Women's Hospital or Dana-Farber Cancer Institute

Age

  • Current age \< 15 years of age

Other

  • Less than 5 years out from initial treatment
  • Relapses within 1 year

Who the study is looking for

  • Patients treated at Brigham and Women's Hospital or Dana-Farber Cancer Institute for Hodgkin's disease with mediastinal irradiation
  • Age \> or = to 15 years of age
  • Five years or longer after initial treatment
  • Relapse-free interval of \> 1 year

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.